Month: November 2016

Vaccitech Launch RIVET Study

Vaccitech has engaged with Primary Care Clinical Trial Unit at Oxford University to run a small pilot study entitled RIVET (Re-inventing Influenza vaccine Efficacy Trials) as a precursor to its large phase IIb (INVICTUS) novel influenza vaccine study scheduled to...

Vaccitech Feature in Jenner Institute Autumn 2016 Newsletter

Vaccitech: Spin out kick starts with £10m from Oxford Sciences Innovation Oxford spin out company Vaccitech was launched in May 2016 with a £10m investment from Oxford Sciences Innovation to take a number of vaccines through clinical trials. The company’s most...